Alginate-based drug oral targeting using bio-micro/nano encapsulation technologies
SR Wagle, B Kovacevic, D Walker… - Expert Opinion on …, 2020 - Taylor & Francis
Introduction Oral delivery is the most common administrated drug delivery path. However,
oral administration of lipophilic drugs has some limitations: they have poor dose-response …
oral administration of lipophilic drugs has some limitations: they have poor dose-response …
A Review of CYP-Mediated Drug Interactions: Mechanisms and In Vitro Drug-Drug Interaction Assessment
J Lee, JL Beers, RM Geffert, KD Jackson - Biomolecules, 2024 - mdpi.com
Drug metabolism is a major determinant of drug concentrations in the body. Drug-drug
interactions (DDIs) caused by the co-administration of multiple drugs can lead to alteration in …
interactions (DDIs) caused by the co-administration of multiple drugs can lead to alteration in …
Study on in vitro metabolism and in vivo pharmacokinetics of Beauvericin
Y Yuan, G Meng, Y Li, C Wu - Toxins, 2022 - mdpi.com
Beauvericin (BEA) is a well-known mycotoxin produced by many fungi, including Beaveria
bassiana. The purpose of this study was to evaluate the in vitro distribution and metabolism …
bassiana. The purpose of this study was to evaluate the in vitro distribution and metabolism …
Synthetic Derivatives against Wild-Type and Non-Wild-Type Sporothrix brasiliensis: In Vitro and In Silico Analyses
LCSV de Souza, LM Alcântara, PA de Macêdo-Sales… - Pharmaceuticals, 2022 - mdpi.com
Recently, the well-known geographically wide distribution of sporotrichosis in Brazil,
combined with the difficulties of effective domestic feline treatment, has emphasized the …
combined with the difficulties of effective domestic feline treatment, has emphasized the …
Computational studies for pre-evaluation of pharmacological profile of gut microbiota-produced gliclazide metabolites
Background Gliclazide, a second-generation sulfonylurea derivative still widely used as a
second-line treatment for type 2 diabetes mellitus, is well known to be subject to …
second-line treatment for type 2 diabetes mellitus, is well known to be subject to …
A review on different analytical strategies for the detection of sertraline: Current challenges and future perspective
Since its inception, selective serotonin reuptake inhibitors (SSRIs), such as sertraline (SRT),
have been an important drug that affects mood and regulates serotonin levels in the …
have been an important drug that affects mood and regulates serotonin levels in the …
Identification of Helicobacter pylori‐carcinogenic TNF‐alpha‐inducing protein inhibitors via daidzein derivatives through computational approaches
JZ Tayyeb, S Mondal, M Anisur Rahman… - Journal of Cellular …, 2024 - Wiley Online Library
Gastric cancer is considered a class 1 carcinogen that is closely linked to infection with
Helicobacter pylori (H. pylori), which affects over 1 million people each year. However, the …
Helicobacter pylori (H. pylori), which affects over 1 million people each year. However, the …
[HTML][HTML] Screening of 16 major drug glucuronides for time-dependent inhibition of nine drug-metabolizing CYP enzymes–detailed studies on CYP3A inhibitors
H Kahma, MN Paludetto, M Neuvonen… - European Journal of …, 2024 - Elsevier
Time-dependent inhibition of cytochrome P450 (CYP) enzymes has been observed for a few
glucuronide metabolites of clinically used drugs. Here, we investigated the inhibitory …
glucuronide metabolites of clinically used drugs. Here, we investigated the inhibitory …
Simultaneous quantification of systemic azoles and their major metabolites in human serum by HPLC/PDA: role of azole metabolic rate
A Gomez-Lopez, L Alcazar-Fuoli… - … and Infectious Disease, 2018 - Elsevier
We describe the development and validation of a novel liquid chromatography assay
(HPLC/PDA) for simultaneous quantification of voriconazole, itraconazole, and …
(HPLC/PDA) for simultaneous quantification of voriconazole, itraconazole, and …
Differential inhibition of human CYP2C8 and molecular docking interactions elicited by sorafenib and its major N-oxide metabolite
The tyrosine kinase inhibitor sorafenib (SOR) is being used increasingly in combination with
other anticancer agents like paclitaxel, but this increases the potential for drug toxicity. SOR …
other anticancer agents like paclitaxel, but this increases the potential for drug toxicity. SOR …